Drug Profile
Research programme: anti-infective therapeutics - Piramal Healthcare
Alternative Names: PM181108Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Piramal Healthcare
- Developer Piramal Enterprises
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Infections in India
- 15 Jun 2012 Preclinical trials in Infections in India (unspecified route)